Total Payments
$2,330
2024 Payments
$225.75
Companies
39
Transactions
130
Medicare Patients
380
Medicare Billing
$37,477
Payment Breakdown by Category
Food & Beverage$1,953 (83.9%)
Education$362.98 (15.6%)
Other$13.23 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,953 | 125 | 83.9% |
| Education | $362.98 | 4 | 15.6% |
| Debt forgiveness | $13.23 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $282.11 | 7 | $0 (2024) |
| Janssen Biotech, Inc. | $248.99 | 11 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $221.40 | 13 | $0 (2023) |
| Merck Sharp & Dohme LLC | $164.02 | 13 | $0 (2023) |
| Amgen Inc. | $149.88 | 9 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $102.43 | 4 | $0 (2023) |
| Celgene Corporation | $92.81 | 6 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $81.71 | 6 | $0 (2022) |
| Seagen Inc. | $80.32 | 2 | $0 (2023) |
| Daiichi Sankyo Inc. | $79.11 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $225.75 | 8 | Astellas Pharma US Inc ($118.34) |
| 2023 | $998.70 | 54 | Novartis Pharmaceuticals Corporation ($221.40) |
| 2022 | $368.45 | 19 | Astellas Pharma US Inc ($113.74) |
| 2021 | $736.70 | 49 | Merck Sharp & Dohme Corporation ($113.07) |
All Payment Transactions
130 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $18.79 | General |
| 09/24/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $22.38 | General |
| Category: ONCOLOGY | ||||||
| 07/18/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Oncology | ||||||
| 07/17/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 03/15/2024 | Astellas Pharma US Inc | Xospata (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Oncology | ||||||
| 01/09/2024 | PFIZER INC. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Oncology | ||||||
| 01/03/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: ONCOLOGY | ||||||
| 12/21/2023 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: ONCOLOGY | ||||||
| 11/17/2023 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug), Vitrakvi | Food and Beverage | In-kind items and services | $31.11 | General |
| Category: Oncology | ||||||
| 11/09/2023 | Pharmacyclics LLC, An AbbVie Company | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2023 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Oncology | ||||||
| 11/02/2023 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Oncology | ||||||
| 10/27/2023 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Oncology | ||||||
| 10/24/2023 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Oncology | ||||||
| 10/14/2023 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Oncology | ||||||
| 10/11/2023 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Oncology | ||||||
| 10/10/2023 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2023 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Oncology | ||||||
| 09/30/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.51 | General |
| 09/21/2023 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug), TASIGNA | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Oncology | ||||||
| 09/12/2023 | ImmunoGen, Inc. | Elahere (Biological) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Oncology | ||||||
| 09/07/2023 | Astellas Pharma US Inc | Xospata (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Oncology | ||||||
| 09/05/2023 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $15.84 | General |
| Category: Hematology | ||||||
| 08/29/2023 | PFIZER INC. | INLYTA (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 244 | 473 | $101,342 | $24,370 |
| 2022 | 2 | 136 | 222 | $53,917 | $13,107 |
Total Patients
380
Total Services
695
Medicare Billing
$37,477
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 190 | 397 | $95,280 | $23,045 | 24.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 14 | $3,458 | $963.76 | 27.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 32 | $2,304 | $327.60 | 14.2% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 20 | 30 | $300.00 | $34.06 | 11.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 63 | 131 | $31,440 | $6,885 | 21.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 73 | 91 | $22,477 | $6,222 | 27.7% |
About Lisa Rouson, APN
Lisa Rouson, APN is a Nurse Practitioner healthcare provider based in Flanders, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2018. The National Provider Identifier (NPI) number assigned to this provider is 1831696467.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lisa Rouson, APN has received a total of $2,330 in payments from pharmaceutical and medical device companies, with $225.75 received in 2024. These payments were reported across 130 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($1,953).
As a Medicare-enrolled provider, Rouson has provided services to 380 Medicare beneficiaries, totaling 695 services with total Medicare billing of $37,477. Data is available for 2 years (2022–2023), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Nurse Practitioner
- Location Flanders, NJ
- Active Since 04/10/2018
- Last Updated 09/11/2024
- Taxonomy Code 363L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1831696467
Products in Payments
- DARZALEX (Biological) $158.45
- KEYTRUDA (Biological) $150.34
- PROMACTA (Drug) $124.68
- Stivarga (Drug) $82.48
- OPDIVO (Biological) $81.71
- Xospata (Drug) $71.58
- Enhertu (Drug) $61.80
- REBLOZYL (Biological) $59.82
- Nplate (Biological) $49.35
- VERZENIO (Drug) $44.93
- LONHALA MAGNAIR (Drug) $42.06
- KRAZATI (Drug) $37.75
- LIBTAYO (Biological) $35.76
- LONSURF (Drug) $34.55
- BRUKINSA (Drug) $31.58
- SCEMBLIX (Drug) $31.08
- ULTOMIRIS (Biological) $30.82
- Lenvima (Drug) $30.47
- EPKINLY (Drug) $29.80
- PLUVICTO (Drug) $29.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.